Use of vanillyl-beta-d-glucopyranoside in the preparation of a drug for liver injury
CN119925397BActive Publication Date: 2025-12-05GUIZHOU MEDICAL UNIV
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CN202510035931.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-01-09
- Publication Date
- 2025-12-05
- Estimated Expiration
- 2045-01-09
Smart Images

Figure CN119925397B_ABST
Abstract
The application belongs to the technical field of medicine, and particularly relates to application of vanillyl-beta-D-glucopyranoside in preparation of liver injury drugs. The application provides, for the first time, application of vanillyl-beta-D-glucopyranoside in preparation of liver injury drugs. Vanillyl-beta-D-glucopyranoside is Vanillyl-beta-D-glucopyranoside (molecular formula is C 14 H 20 O8; molecular weight is 316.3, and is referred to as VA hereinafter). The drug VA does not show toxicity in a concentration range (6.25-100 muM) under investigation, can significantly improve cell survival rate of liver parenchymal cells AML-12 induced by acetaminophen, has a significant liver protection effect, and has a good application prospect in preparation of liver injury prevention and treatment drugs.
Need to check novelty before this filing date? Find Prior Art